Targeting metallo-β-lactamase enzymes in antibiotic resistance

Future Medicinal Chemistry

Volumn 5, Issue 11, 2013, Pages 1243-1263

  King, Dustin T ^a   Strynadka, Natalie C J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; BETA LACTAM ANTIBIOTIC; BIPHENYL DERIVATIVE; BIPHENYL TETRAZOLE; CEPHALOSPORIN DERIVATIVE; CYCLOBUTANONE DERIVATIVE; DICARBOXYLIC ACID DERIVATIVE; DNA; HETEROCYCLIC DICARBOXYLIC ACID; MERCAPTOACETIC ACID THIOESTER DERIVATIVE; METALLO BETA LACTAMASE; PENICILLIN DERIVATIVE; PEPTIDE INHIBITOR; PROTEIN INHIBITOR; PYRIDINE DERIVATIVE; PYRROLE DERIVATIVE; SUCCINIC ACID DERIVATIVE; TETRAZOLE DERIVATIVE; THIOGLYCOLIC ACID DERIVATIVE; THIOL DERIVATIVE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; ZINC ION;

ANTIBIOTIC RESISTANCE; CHELATION; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME STRUCTURE; HYDROLYSIS; PRIORITY JOURNAL; REVIEW;

APTAMERS, NUCLEOTIDE; BACTERIA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CATALYTIC DOMAIN; CEPHALOSPORINS; CYCLOBUTANES; ENZYME INHIBITORS; HUMANS; PENICILLINS; SULFHYDRYL COMPOUNDS;

EID: 84893391938     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.13.55     Document Type: Review

References (82)

1. Page MGP. Beta-lactam antibiotics. In: Antibiotic Discovery and Development. Dougherty TJ, Pucci MJ (Eds). Springer, NY, USA, 79-117 (2012).
2. Waxman DJ, Strominger JL. Penicillin-binding proteins and the mechanism of action of b-lactam antibiotics. Annu. Rev. Biochem. 52, 825-869 (1983).
3. Abraham EP, Chain E. An enzyme from bacteria able to destroy penicillin. Nature 146, 837-837 (1940).
4. Bebrone C. Metallo-b-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem. Pharmacol. 74(12), 1686-1701 (2007).
5. Sabath LD, Abraham EP. Zinc as a cofactor for cephalosporinase from Bacillus cereus 569. Biochem. J. 98(1), 11c-13c (1966).
6. Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 35, 147-151 (1991).
7. Rasmussen BA, Gluzman Y, Tally FP. Cloning and sequencing of the class B beta-lactamase gene (CcrA) from Bacteriodes fragilis TAL3636. Antimicrob. Agents Chemother. 34, 1590-1592 (1990).
8. Massidda O, Rossolini GM, Satta G. The Aeromonas hydrophila CphA gene: Molecular heterogeneity among class B metallo-beta-lactamases. J. Bacteriol. 173, 4611-4617 (1991).
9. Carfi A, Pares S, Duée E, et al.: The 3-D structure of a zinc metallo-beta-lactamase from Bacillus cereus reveals a new type of protein fold. EMBO J. 14(20), 4914-4921 (1995).
10. Galleni M, Lamotte-Brasseur J, Rossolini GM, Spencer J, Dideberg O, Frère J. Standard numbering scheme for class B b-lactamases. Antimicrob. Agents Chemother. 45(3), 660-663 (2001).
11. Brogden RN, Heel RC. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 31(2), 96-130 (1986).
12. Poirel L, Revathi G, Bernabeu S, Nordmann P. Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrob. Agents Chemother. 55(2), 934-936 (2011).
13. Gatti DL. Biapenem inactivation by B2 metallo b-lactamase: Energy landscape of the post-hydolysis reactions. PLoS ONE doi:10.1371/journal.pone. 0030079 (2012) (Epub ahead of print).
14. Siemann S, Brewer D, Clarke AJ, Dmitrienko GI, Lajoie G, Viswanatha T. IMP-1 metallo-beta-lactamase: Effects of chelators and assessment of metal requirement by electrospray mass spectrometry. Biochem. Biophys. Acta 1571(3), 190-200 (2002).
15. Singh S, Khodr H, Taylor MI, Hider RC. Therapeutic iron chelators and their potential side-effects. Biochem. Soc. Symp. 61, 127-138 (1995).
16. Sutton BJ, Artymiuk PJ, Cordero-Borboa AE, Little C, Phillips DC, Waley SG. An x-ray-crystallographic study of b-lactamase II from Bacillis cereus at 0.35 nm resolution. Biochem J. 248, 181-188 (1987).
17. Wang Z, Fast W, Valentine AM, Benkovic SJ. Metallo-b-lactamase: Structure and mechanism. Curr. Opin. Chem. Biol. 3(5), 614-622 (1999).
18. Merino M, Pérez-Llarena FJ, Kerff F, et al.: Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-Type metallo-b-lactamases. J. Antimicrob. Chemother. 65(9), 1950-1954 (2010).
19. King D, Strynadka N. Crystal structure of New Delhi metallo-b-lactamase reveals molecular basis for antibiotic resistance. Protein Sci. 20(9), 1484-1491 (2011).
20. Garcia-Saez I, Docquier J, Rossolini GM, Dideberg O. The three-dimensional structure of VIM-2, a Zn-b-lactamase from Pseudomonas aeruginosa in its reduced and oxidized form. J. Mol. Biol. 375, 604-611 (2008).
21. Concha NO, Janson CA, Rowling P, et al.: Crystal Structure of the IMP-1 metallo b-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: Binding determinants of a potent, broad-spectrum inhibitor. Biochemistry 39, 4288-4298 (2000).
22. Moali C, Anne C, Lamotte-Brasseur J, Groslambert S, Devreese B, Van Beeuman J. Analysis of the importance of the metallo-b-lactamase active site loop in substrate binding and catalysis. Chem. Biol. 10, 319-329 (2003).
23. Garau G, Bebrone C, Anne C, Galleni M, Frère J, Dideberg O. A metallo-b-lactamase enzyme in action: Crystal structures of the monozinc carbapenemase CphA and its complex with biapenem. J. Mol. Biol. 345(4), 785-795 (2004).
24. Schenk G, Mitic N, Gahan LR, Ollis DL, McGeary RP, Guddat LW. Binuclear metallohydrolases: Complex mechanistic strategies for a simple chemical reaction. Acc. Chem. Res. 45(9), 1593-1603 (2012).
25. Page MI, Badarau A. The mechanisms of catalysis by metallo b-lactamases. Bioinorg. Chem. Appl. 2008, 576297 (2008).
26. Garcia-Saez I, Mercuri PS, Papamicael C, et al.: Three-dimensional structure of FEZ-1, a monomeric subclass B3 metallo-beta-lactamase from Fluoribacter gormanii, in native form and in complex with d-captopril. J. Mol. Biol. 325, 651-660 (2003).
27. Kim Y, Tesar C, Jedrzejczak R, et al.: Structure of Apo-And monometalated forms of NDM-1-A highly potent carbapenem-hydrolyzing metallo-b-lactamase. PLoS ONE 6(9), e24621 (2011).
28. Peraro MD, Vila AJ, Carloni P, Klein ML. Role of zinc content on the catalytic efficiency of B1 metallo b-lactamases. J. Am. Chem. Soc. 129(10), 2808-2816 (2007).
29. Materon IC, Beharry Z, Huang W, Perez C, Palzkill T. Analysis of the context dependent sequence requirements of active site residues in the metallo-b-lactamase IMP-1. J. Mol. Biol. 344(3), 653-663 (2004).
30. Zhang H, Hao Q. Crystal structure of NDM-1 reveals a common b-lactam hydrolysis mechanism. FASEB J. 25(8), 2574-2582 (2011).
31. King DT, Worrall LJ, Gruninger R, Strynadka NCJ. New Delhi metallo-b-lactamase: Structural insights into b-lactam recognition and inhibition. J. Am. Chem Soc. 134(28), 11362-11365 (2012).
32. Xu D, Xie D, Guo H. Catalytic mechanism of class B2 metallo-b-lactamase. J. Biol. Chem. 281(13), 8740-8747 (2006).
33. Fonseca F, Bromley EH, Saavedra MJ, Correia A, Spencer J. Crystal structure of Serratia fonticola Sfh-I: Activation of the nucleophile in mono-zinc metallo-b-lactamases. J. Mol. Biol. 411, 951-959 (2011).
34. Spencer J, Read J, Sessions RB, Howell S, Blackburn GM, Gamblin SJ. Antibiotic recognition by binuclear metallo-beta-lactamases revealed by x-ray crystallography. J. Am. Chem. Soc. 127, 14439-14444 (2005).
35. Pagès J-M, James CE, Winterhalter M. The porin and the permeating antibiotic: A selective barrier in Gram-negative bacteria. Nat. Rev. Microbiol. 6(12), 893-903 (2008).
36. Murphy, Brian P, Pratt RF. A thiono-beta-lactam substrate for the beta-lactamase II of Bacillus cereus. Evidence for the direct interaction between the essential metal ion and substrate. Biochem. J. 258, 765-768 (1989).
37. Tsang WY, Dhanda A, Schofield CJ, Frère J-M, Galleni M, Page MI. The inhibition of metallo-b-lactamase by thioxo-cephalosporin derivatives. Bioorg. Med. Chem. Lett. 14, 1737-1739 (2004).
38. Badarau A, Llinás A, Laws AP, et al.: Inhibitors of metallo-b-lactamase generated from b-lactam antibiotics. Biochemistry. 44, 8578-8589 (2005).
39. Zervosen A, Valladares MH, Devreese B, et al.: Inactivation of Aeromonas hydrophila metallo-b-lactamase by cephamycins and moxalactam. Eur. J. Biochem. 268, 3840-3850 (2001).
40. Buynak JD, Chen H, Vogeti L, et al.: 2004. Penicillin-derived inhibitors that simultaneously target both metallo-And serine-beta-lactamases. Bioorg. Med. Chem. Lett. 14(5), 1299-1304 (2004).
41. Moali C, Anne C, Lamotte-Brasseur J, et al.: Analysis of the importance of the metallo-b-lactamase active site loop in substrate binding and catalysis. Chem. Biol. 10(4), 319-329 (2003).
42. Scrofani SDB, Chung J, Huntley JJA, Benkovic SJ, Wright PE, Dyson HJ. NMR characterization of the metallo-b-lactamase from Bacteriodes fragilis and its interaction with a tight-binding inhibitor: Role of an active-site loop. Biochemistry. 38, 14507-14514 (1999).
43. Nagano R, Adachi Y, Imamura H, Yamada K, Hashizume T, Morishima H. Carbapenem derivatives as potential inhibitors of various b-lactamases, including class B metallo-b-lactamases. Antimicrob. Agents Chemother. 43(10), 2497-2503 (1999).
44. Nagano R, Adachi Y, Hashizume T, Morishima H. In vitro antibacterial activity and mechanism of action of J-111,225, a novel 1b-methylcarbapenem, against transferable IMP-1 metallo-b-lactamase producers. J. Antimicrob. Chemother. 45, 271-276 (2000).
45. Venkatesan AM, Agarwal A, Abe T, et al.: Structure-Activity relationship of 6-methylidene penems bearing 6,5 bicyclic heterocycles as broad-spectrum b-lactamase inhibitors: Evidence for 1,4-Thiazopine intermediates with C7 R stereochemistry by computational methods. J. Med. Chem. 49. 4623-4637 (2006).
46. Johnson JW, Evanoff DP, Savard ME, et al.: Cyclobutanone mimics of penicillins: Effects of substitution on conformation and hemiketal stability. J. Org. Chem. 73, 6970-6982 (2008).
47. Johnson JW, Gretes M, Goodfellow VJ, et al.: Cyclobutanone analogues of b-lactams revisited: Insights into conformational requirements for inhibition of serine-And Metallo-b-lactamases. J. Am. Chem. Soc. 132, 2558-2560 (2010).
48. Maret W. Zinc and sulfur: A critical biological partnership. Biochemistry. 43(12), 3301-3309 (2004).
49. Heinz U, Bauer R, Wommer S, et al.: Coordination geometries of metal ions in d-or l-captopril-inhibited metallo-b-lactamases. J. Biol. Chem. 278(23), 20659-20666 (2003).
50. García-Sáez I, Hopkins J, Papamicael C, et al.: The 1.5Å Structure of Chryseobacterium meningosepticum zinc b-lactamase in complex with the inhibitor, d-captopril. J. Biol. Chem. 278, 23868-23873 (2004).
51. Nauton L, Kahn R, Garau G, Hernandez JF, Dideberg O. Structural insights into the design of inhibitors for the L1 metallo-b-lactamase from Stenotrophomonas maltophilia. J. Mol. Biol. 375, 257-269 (2008).
52. Liénard BM, Garau L, Horsfall L, et al.: Structural basis for the broad-spectrum inhibition of metallo-beta-lactamases by thiols. Org. Biomol. Chem. 6(13), 2282-2294 (2008).
53. Sun Q, Law A, Crowder MW, Geysen HM. Homo-cysteinyl peptide inhibitors of the L1 metallo-b-lactamase, and SAR as determined by combinatorial library synthesis. Bioorg. Med. Chem. Lett. 16(19), 6169-5175 (2006).
54. Bounaga S, Galleni M, Laws AP, Page MI. Cyseinyl peptide inhibitors of Bacillus cereus zinc b-lactamase. Bioorg. Med. Chem. 9, 503-510 (2001).
55. Yamaguchi Y, Jin W, Matsunaga K, et al.: Crystallographic investigation of the inhibition mode of a VIM-2 metallo-b-lactamase from Pseudomonas aeruginosa by a mercaptocarboxylate inhibitor. J. Med. Chem. 50, 6647-6653 (2007).
56. Goto M, Takahashi T, Yamashita F, et al.: Inhibition of the metallo-b-lactamase produced from Serratia marcescens by thiol compounds. Biol. Pharm. Bull. 20(11), 1136-1140 (1997).
57. Mollard C, Moali C, Papamicael C, et al.: Thiomandelic acid, a broad spectrum inhibitor of zinc beta-lactamases: Kinetic and spectroscopic studies. J. Biol. Chem. 276(48), 45015-45023 (2001).
58. Damblon C, Jensen M, Ababou A, et al.: The inhibitor thiomandelic acid binds to both metal ions in metallo-b-lactamase and induces positive cooperativity in metal binding. J. Biol. Chem. 278(31), 29240-29251 (2003).
59. Kurosaki H, Yamaguchi Y, Yasuzawa H, Jin W, Yamagata Y, Arakawa Y. Probing, inhibition, and crystallographic characterization of metallo-b-lactamase (IMP-1) with fluorescent agents containing dansyl and thiol groups. Chem Med Chem 1, 969-972 (2006).
60. Kurosaki H, Yamaguchi Y, Higashi T, et al.: Irreversible inhibition of metallo-b-lactamase (IMP-1) by 3-(3-mercaptopropionylsulfanyl)-propionic acid pentafluorophenyl ester. Angew. Chem. Int. Ed. Engl. 44, 3861-3864 (2005).
61. Toney JH, Hammond GG, Fitzgerald PMD, et al.: Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-b-lactamase. J. Biol. Chem. 276(34), 31913-31918 (2001).
62. Moloughney JG, Thomas J, Toney JH. Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1. FEMS Microbiol. Lett. 243(1), 65-71 (2005).
63. Ishii Y, Eto M, Mano Y, Tateda K, Yamaguchi K. In vitro potentiation of carbapenems with ME1071, a novel metallo-b-lactamase producing Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 54(9), 3625-3629 (2010).
64. Hiraiwa Y, Morinaka A, Fukushima T, et al.: Metallo-b-lactamase inhibitory activity of phthalic acid derivatives. Bioorg. Med. Chem. Lett. 19, 5162-5165 (2009).
65. Payne DJ, Bateson JH, Gasson BC, et al.: Inhibition of metallo-b-lactamases by a series of mercaptoacetic acid thiol derivatives. Antimicrob. Agents Chemother. 41(1), 135-140 (1997).
66. Payne DJ, Bateson JH, Gasson BC, et al.: Inhibition of metallo-b-lactamases by a series of thiol ester derivatives of mercaptophenylacetic acid. FEMS Microbiol. Lett. 157, 171-175 (1997).
67. Hammond GG, Huber JL, Greenlee ML, et al.: Inhibition of IMP-1 metallo-b-lactamase and sensitization of IMP-1-producing bacteria by thioester derivatives. FEMS Microbiol. Lett. 459, 289-296 (1999).
68. Greenlee ML, Laub JB, Balkovec JM, et al.: Synthesis and SAR of thioester and thiol inhibitors of IMP-1 metallo-b-lactamase. Bioorg. Med. Chem. Lett. 9, 2549-2554 (1999).
69. Hussein WM, Fatahala SS, Mohamed ZM, et al.: Synthesis and kinetic testing of tetrahydropyrimidine-2-Thione and pyrrole derivatives as inhibitors of the metallo-b-lactamase from Klebsiella pneumonia and Pseudomonas aeruginosa. Chem. Biol. Drug Des. 80(4), 500-515 (2012).
70. Mohamed MS, Hussein WM, McGeary RP, Vella P, Schenk G, Abd El-Hameed RH. Synthesis and kinetic testing of new inhibitors for a metallo-b-lactamase from Klebsiella pneumonia and Pseudomonas aeruginosa. Eur. J. Med. Chem. 46(12), 6075-6082 (2011).
71. Horsfall LE, Garau G, Liénard BMR, et al.: Competitive inhibitors of the CphA metallo-b-lactamase from Aeromonas hydrophila. Antimicrob. Agents Chemother. 51(6), 2136-2142 (2007).
72. Olsen L, Jost S, Adolph H-W, Pettersson I, Hemmingsen L, Jørgensen FS. New leads of metallo-b-lactamase inhibitors from structure-based pharmacore design. Bioorg. Med. Chem. 14, 2627-2635 (2006).
73. Weide T, Saldanha SA, Minond D, et al.: NH-1,2,3-Triazole inhibitors of the VIM-2 metallo-b-lactamase. ACS Med. Chem. Lett. 1(4), 150-154 (2010).
74. Kim S-K, Sims CL, Wozniak SE, Drude SH, Whitson D, Shaw RW. Antibiotic resistance in bacteria: Novel metallo-enzyme inhibitors. Chem. Biol. Drug Des. 74, 343-348 (2009).
75. Sanschagrin F, Levesque RC. A specific peptide inhibitor of the class B metallo-b-lactamase L-1 from Stenotrophomonas maltophilia identified using phage display. J. Antimicrob. Chemother. 55, 252-255 (2005).
76. Payne DJ, Hueso-Rodríguez JA, Boyd H, et al.: Identification of a series of tricylic natural products as potent broad-spectrum inhibitors of metallo-b-lactamase. Antimicrob. Agents Chemother. 46, 1880-1886 (2002).
77. Siemann S, Evanoff DP, Marrone L, Clarke AJ, Viswanatha T, Dmitrienko GI. N-Arylsulfonyl hydrazones as inhibitors of IMP-1 metallo-b-lactamase. Antimicrob. Agents Chemother. 46(8), 2450-2457 (2002).
78. Payne DJ, Cramp R, Bateson JH, Neale J, Knowles D. Rapid identification of metallo-And serine b-lactamases. Antimicrob. Agents Chemother. 38(5), 991-996 (1994).
79. Aoki N, Ishii Y, Tateda K, et al.: Efficacy of calcium-EDTA as an inhibitor for metallo-b-lactamase in a mouse model of Pseudomonas aeruginosa pneumonia. Antimicrob. Agents Chemother. 54(11), 4582-4588 (2010).
80. Toney JH, Fitzgerald PMD, Grover-Sharma N, et al.: Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-b-lactamase. Chem. Biol. 5, 185-196 (1998).
81. Toney JH, Cleary KA, Hammond GG, et al.: Structure-Activity relationships of biphenyl tetrazoles as metallo-b-lactamase Inhibitors. Bioorg. Med. Chem Lett. 9, 2741-2746 (1999).
82. Feng L, Yang K-W, Zhou L-S, et al.: N-Heterocyclic dicarboxylic acids: Broad-spectrum inhibitors of metallo-b-lactamases with co-Antibacterial effect against antibiotic-resistant bacteria. Bioorg. Med. Chem. Lett. 22, 5185-5189 (2012).